MindImmune Therapeutics closes $500K seed round led by Slater Fund

MINDIMMUNE THERAPEUTICS is a South Kingstown-based pharmaceutical startup. Above, the MindImmune Therapeutics lab at the University of Rhode Island. /COURTESY MINDIMMUNE THERAPEUTICS
MINDIMMUNE THERAPEUTICS is a South Kingstown-based pharmaceutical startup. Commerce RI awarded the company a $50,000 Innovation Voucher grant to partner with the University of Rhode Island and establish animal models of brain immune system dysfunction, as a means to screen for new Alzheimer’s disease therapies. Above, the MindImmune Therapeutics lab at the University of Rhode Island. /COURTESY MINDIMMUNE THERAPEUTICS
PROVIDENCE – MindImmune Therapeutics Inc., a pharmaceutical startup, closed its second seed round of $500,000 on Monday. The round was led by a $250,000 investment from Slater Technology Fund, a publicly funded venture capital firm in Providence. MindImmune, based out of the University of Rhode Island, is developing drugs to target the immune system as…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -